デフォルト表紙
市場調査レポート
商品コード
1009556

オリゴヌクレオチド治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)

Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
オリゴヌクレオチド治療薬の世界市場の分析 (2021年):新型コロナウイルス感染症 (COVID-19) の中での成長と変化 (2030年まで)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のオリゴヌクレオチド治療薬の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し、セグメント別 (種類別・用途別) および地域別・主要国の詳細動向、主要企業のプロファイル、近年の主な傾向、今後の市場機会などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 オリゴヌクレオチド治療薬市場の特徴

第3章 オリゴヌクレオチド治療薬市場の傾向と戦略

第4章 オリゴヌクレオチド治療薬市場に対する新型コロナウイルス感染症 (COVID-19) の影響

第5章 オリゴヌクレオチド治療薬市場:市場規模・成長率

  • 市場規模 (金額ベース、2015年~2020年)
    • 市場促進要因
    • 市場抑制要因
  • 市場規模 (金額ベース、2020年~2025年、2030年)
    • 市場促進要因
    • 市場抑制要因

第6章 オリゴヌクレオチド治療薬市場:分野別の分析

  • 種類別の市場規模 (金額ベース、2015年~2020年/2020年~2025年/2030年)
  • アンチセンスオリゴヌクレオチド
  • アプタマー
  • その他
  • 用途別の市場規模 (金額ベース、2015年~2020年/2020年~2025年/2030年)
  • 感染症
  • 腫瘍
  • 神経変性疾患
  • 心血管疾患
  • 腎臓病
  • その他
  • エンドユーザー別の市場規模 (金額ベース、2015年~2020年/2020年~2025年/2030年)
  • 病院
  • 研究機関

第7章 オリゴヌクレオチド治療薬市場:地域別・国別分析

  • 地域別の市場規模 (金額ベース、2015年~2020年/2020年~2025年/2030年)
  • 国別の市場規模 (金額ベース、2015年~2020年/2020年~2025年/2030年)

第8章 アジア太平洋のオリゴヌクレオチド治療薬市場

  • 市場概要
  • 地域情報
  • 種類別の市場規模 (金額ベース、2015年~2020年/2020年~2025年/2030年)
  • 用途別の市場規模 (金額ベース、2015年~2020年/2020年~2025年/2030年)

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧のオリゴヌクレオチド治療薬市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 東欧のオリゴヌクレオチド治療薬市場

第20章 ロシア市場

第21章 北米のオリゴヌクレオチド治療薬市場

第22章 米国市場

第23章 南米のオリゴヌクレオチド治療薬市場

第24章 ブラジル市場

第25章 中東のオリゴヌクレオチド治療薬市場

第26章 アフリカのオリゴヌクレオチド治療薬市場

第27章 オリゴヌクレオチド治療薬市場:競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Alnylam Pharmaceuticals Inc.
    • Biogen Inc.
    • Dynavax Technologies Corp.
    • Ionis Pharmaceuticals Inc.
    • Merck & Co. Inc.

第28章 オリゴヌクレオチド治療薬のパイプライン製品の分析

第29章 オリゴヌクレオチド治療薬市場における主要な企業合併・買収 (M&A)

第30章 オリゴヌクレオチド治療薬市場:将来展望と潜在力の分析

第31章 付録

目次

Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oligonucleotide therapy market.

This report focuses on oligonucleotide therapy market which is experiencing strong growth. The report gives a guide to the oligonucleotide therapy market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the oligonucleotide therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oligonucleotide Therapy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider oligonucleotide therapy market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The oligonucleotide therapy market section of the report gives context. It compares the oligonucleotide therapy market with other segments of the oligonucleotide therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oligonucleotide therapy indicators comparison.

Scope

Markets Covered: 1) By Type: Antisense Oligonucleotide; Aptamer; Other

2) By Application: Infectious Diseases; Oncology; Neurodegenerative Disorders; Cardiovascular Diseases; Kidney Diseases; Others

3) By End User: Hospitals; Research Institutes

Companies Mentioned: Alnylam Pharmaceuticals Inc.; Biogen Inc.; Dynavax Technologies Corp.; Ionis Pharmaceuticals Inc.; Merck & Co. Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Oligonucleotide Therapy Market Characteristics

3. Oligonucleotide Therapy Market Trends And Strategies

4. Impact Of COVID-19 On Oligonucleotide Therapy

5. Oligonucleotide Therapy Market Size And Growth

  • 5.1. Global Oligonucleotide Therapy Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Oligonucleotide Therapy Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Oligonucleotide Therapy Market Segmentation

  • 6.1. Global Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Antisense Oligonucleotide
  • Aptamer
  • Other
  • 6.2. Global Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Infectious Diseases
  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular Diseases
  • Kidney Diseases
  • Others
  • 6.3. Global Oligonucleotide Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Research Institutes

7. Oligonucleotide Therapy Market Regional And Country Analysis

  • 7.1. Global Oligonucleotide Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Oligonucleotide Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Oligonucleotide Therapy Market

  • 8.1. Asia-Pacific Oligonucleotide Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Oligonucleotide Therapy Market

  • 9.1. China Oligonucleotide Therapy Market Overview
  • 9.2. China Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Oligonucleotide Therapy Market

  • 10.1. India Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Oligonucleotide Therapy Market

  • 11.1. Japan Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Oligonucleotide Therapy Market

  • 12.1. Australia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Oligonucleotide Therapy Market

  • 13.1. Indonesia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Oligonucleotide Therapy Market

  • 14.1. South Korea Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Oligonucleotide Therapy Market

  • 15.1. Western Europe Oligonucleotide Therapy Market Overview
  • 15.2. Western Europe Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Oligonucleotide Therapy Market

  • 16.1. UK Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Oligonucleotide Therapy Market

  • 17.1. Germany Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Oligonucleotide Therapy Market

  • 18.4. France Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Oligonucleotide Therapy Market

  • 19.1. Eastern Europe Oligonucleotide Therapy Market Overview
  • 19.2. Eastern Europe Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Oligonucleotide Therapy Market

  • 20.1. Russia Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Oligonucleotide Therapy Market

  • 21.1. North America Oligonucleotide Therapy Market Overview
  • 21.2. North America Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Oligonucleotide Therapy Market

  • 22.1. USA Oligonucleotide Therapy Market Overview
  • 22.2. USA Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Oligonucleotide Therapy Market

  • 23.1. South America Oligonucleotide Therapy Market Overview
  • 23.2. South America Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Oligonucleotide Therapy Market

  • 24.1. Brazil Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Oligonucleotide Therapy Market

  • 25.1. Middle East Oligonucleotide Therapy Market Overview
  • 25.2. Middle East Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Oligonucleotide Therapy Market

  • 26.1. Africa Oligonucleotide Therapy Market Overview
  • 26.2. Africa Oligonucleotide Therapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Oligonucleotide Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Oligonucleotide Therapy Market Competitive Landscape And Company Profiles

  • 27.1. Oligonucleotide Therapy Market Competitive Landscape
  • 27.2. Oligonucleotide Therapy Market Company Profiles
    • 27.2.1. Alnylam Pharmaceuticals Inc.
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Biogen Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Dynavax Technologies Corp.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Ionis Pharmaceuticals Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Merck & Co. Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Oligonucleotide Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Oligonucleotide Therapy Market

30. Oligonucleotide Therapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer